This article explores the latest developments in the life insurance sector, examines factors influencing premium rates, and highlights the role of term insurance in providing cost-effective coverage.
Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and genomic testing and precision medicine, announced that a MyRisk ® Hereditary Cancer Test with RiskScore ® study has been named in the ...